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Canine hip dysplasia (CHD) is a genetic disease, modulated by epigenetic and
environmental factors. To decrease the prevalence of CHD, the hip joints of many pure
breed dogs are radiographed to identify dysplastic dogs not qualified for breeding. It has
been shown that both, prevalence and severity of CHD may be reduced on the basis
of phenotypic i.e., radiographic selection of breeding animals. The method has been
used in many countries for over 50 years. In the present study, severity and prevalence
of CHD in five common large breeds in Switzerland were evaluated since 1995. Both,
prevalence and severity of CHD dropped in each breed between the periods 1995–1999
and 2010–2016. The prevalence decreased in Golden Retrievers from 25 to 9% and in
Labrador Retrievers from 16 to 3%, respectively. In the Flat-Coated Retriever, prevalence
in general was low, decreasing from 6 to 3%. In the Bernese mountain dog and the
German shepherd dog, a decrease from 21 to 12% and from 46 to 18%, respectively,
was observed. However, the rather low overall rate of radiographed dogs (Retrievers:
11 to 18%, Bernese Mountain dogs: 23% and German Shepherd dogs: 31%) does not
allow to draw reliable conclusions regarding the true prevalence of CHD for the entire
population of these breeds in Switzerland.
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INTRODUCTION
Canine hip dysplasia (CHD) is defined as a developmental disease of the coxofemoral joint (1)
and occurs in most canine breeds. The joint appears normal and congruent at birth but develops
abnormal during growth. Excessive laxity is assumed to be the key factor leading to subluxation
of the femoral head, incongruity of the joint and subsequent flattening of the acetabulum (2). As
a result, the load on the cartilage is unevenly distributed resulting in unequal cartilage abrasion,
followed by an inflammatory response and finally secondary degenerative joint disease, causing
pain and lameness (1, 3). Presence and degree of CHDmay be assessed on the basis of radiographic
changes, i.e., subluxation, joint deformation, and osteoarthritis (4).
Canine hip dysplasia is a multifactorial disease triggered by genetic, environmental and probably
epigenetic factors (5, 6). The genetic basis of CHD is not fully understood; however, it is assumed
to be a complex genetic trait with a polygenic inheritance pattern. Both, dominant and recessive
modes of inheritance have been discussed (7, 8). Due to its genetic background, excluding affected
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dogs from breeding may reduce the prevalence of CHD. The
heritability of CHD and therefore the response to selection is
breed dependent. The higher the heritability of a trait, the greater
is the expected genetic improvement over time when selective
breeding is practiced (9, 10). Breeding stock is usually selected
based on the radiographic phenotype.
The radiographic projection in dorsal recumbency with
extended hip joints is used for assessment of CHD in most
countries (11). In Switzerland, a second view with flexed and
abducted stifles is mandatory for official scoring to improve
scoring quality (12). Minimum age of the dogs for official scoring
is between 12 and 24 months, depending on the country and the
scoring method used.
Prevalence of CHD has been reported to vary significantly
between breeds and countries. In France, the prevalence varied
between 3.9% (Siberian Husky) and 59.7% (Cane Corso) over the
period 1993–2006 (13). In the United States, values of 1.5% in
the Miniature Schnauzer and 35.4% in Rottweilers were reported
between 1991 and 1995 (14). In Switzerland between 1991 and
1994, the CHD-prevalence ranged from 7% in Siberian Huskies
to 69% in Gordon Setters. For popular breeds such as the
Retrievers, the Bernese mountain dog and the German shepherd
dog, prevalence of CHD was in the range of 31–53% (15). During
the last decades many selective breeding programs based on the
radiographic scoring have been implemented for different breeds
with the aim to reduce the prevalence and severity of CHD,
and consequently, to improve animal’s welfare. A decrease of the
CHD-prevalence was noted in some reports (13, 16, 17); however,
progress was slow or inexistent in others (18, 19).
Reports of the recent prevalence of CHD in Switzerland are
lacking in the peer-reviewed literature. The aim of the present
study was therefore to assess the overall prevalence of CHD
and its change since 1995 in five common large dog breeds
in Switzerland.
MATERIALS AND METHODS
Animals
The largest purebred dog populations in Switzerland i.e., Golden
Retrievers, Labrador Retrievers, Flat Coated Retrievers, Bernese
Mountain dogs and German Shepherd dogs were included in the
study. The Swiss kennel clubs provided the official CHD score
TABLE 1 | Comparison of scoring protocols for canine hip dysplasia.
Switzerland
(point score
per joint)
FCI BVA/KC
(point score
per joint)
OFA
0–2 A: normal 0–3 Excellent
3–6 B: near normal 4–8 Good
7–12 C: mild CHD 9–18 Fair, borderline, mild
13–18 D: moderate CHD >18 Moderate
>18 E: severe CHD Severe
FCI, Fédération Cynologique Internationale, BVA/KC, British Veterinary Association/The
Kennel Club, OFA, Orthopedic Foundation for Animals.
and the date of birth for each dog. The vast majority of the dogs
were examined in their second year of life.
Scoring Protocols
Most dogs were scored according to the Swiss scoring system (4).
Ninety-six imported dogs had been scored abroad; for the present
study their scores were transferred to the Swiss system as shown
in Table 1.
The Orthopedic Foundation for Animals (OFA) system is
used in the USA and Canada. Minimum age for scoring is 2
years. Seven grades are defined: excellent, good, fair, borderline,
mild, moderate, or severe. The borderline grade is assigned
to incongruent joints of undetermined quality but without
degenerative changes. The British Veterinary Association/The
Kennel Club (BVA/KC) system is used in Britain, Ireland,
Australia and New Zealand. Dogs older than 12 months are
evaluated. Nine radiographic criteria are evaluated; each rated
with 0–5, or 0–6 points, respectively (20, 21). A total between
0 and 52 points is allotted to each joint. In Britain, the points
per joint are added up representing the final score whereas in
Australia only the total points of the worse hip joint is used for
the final score (22). The Fédération Cynologique Internationale
FIGURE 1 | (A) Distribution of CHD-grades in the Swiss Golden Retriever
population from 1995 to 2016. (B) Proportion of dysplastic and CHD-free
Golden Retrievers in Switzerland from 1995 to 2016: the prevalence of CHD
dropped markedly over 22 years.
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(FCI) system is used in most European countries, Russia, South
America, and Asia (23). Minimum age for official scoring is 12
months, in giant breeds 18 months (24). Each joint is allotted
to one of five grades (A–E) that are defined descriptively; the
final grade refers to the worse joint. In Switzerland a system
is used linking the British system with the FCI grading system
allowing a more systematic and objective scoring. The same six
radiographic criteria as in the FCI system are evaluated; each
criterion is allotted 0–5 points leading to a sum of 0–30 points
per joint. Criteria 1 and 2 quantify the degree of laxity. Criteria
3 and 4 determine modeling of the acetabulum and criteria 5
and 6 include arthritic changes of the femoral head and neck (4).
The numeric score is then translated into the FCI-grades A–E
(23). For the Bernese mountain dog the minimal age for official
scoring in Switzerland is 14 months, whereas it is 12 months for
the Retriever breeds and the German shepherd dog.
Statistical Analysis
The kennel clubs provided data on birth rate and official
CHD score. Descriptive statistics was performed using the SPSS
statistics program (Version 19, IBM Corporation, Armonk,
New York). Hip dysplasia grades A and B were considered
FIGURE 2 | (A) Distribution of CHD-grades in the Swiss Labrador Retriever
population from 1995 to 2016. (B) Proportion of dysplastic and CHD-free
Labrador Retrievers in Switzerland from 1995 to 2016: the prevalence of CHD
decreased over 22 years.
normal joints (CHD-free) whereas the grades C, D, and E were
considered dysplastic.
RESULTS
Prevalence of the five CHD-grades and prevalence of dysplastic
dogs are shown for each breed from 1995–2016 in Figures 1–5.
Golden Retriever
The Swiss retriever club registered an official CHD-score for
1047 Golden Retrievers between 1995 and 2016. Of these dogs,
27 (2.6%) were scored abroad (BVA/KC system). The overall
prevalence of CHD was 15.8% including 14.4, 1.0, and 0.4% dogs
with grade C, D, and E, respectively. Of the 84.2%CHD-free dogs,
41.6% were scored grade A and 42.6% grade B, respectively. In
the first period (1995–1999), 25.3% of the Golden Retrievers were
dysplastic whereas in the final period (2010–2016) the prevalence
of CHD had dropped to 9.4%.Most remarkable were the decrease
of dogs with grade C (from 25.3 to 9.0%) and the increase of A-
scored dogs (from 24.1 to 53.5%). The fraction of A and B joints
reached∼90% in 2004 and remained unchanged ever since.
FIGURE 3 | (A) Distribution of CHD-grades in the Swiss Flat-Coated Retriever
population from 1995 to 2016. (B) Proportion of dysplastic and CHD-free
Flat-Coated Retrievers in Switzerland from 1995 to 2016: in comparison to the
other breeds, the prevalence of CHD has been markedly lower and values
stayed constant during the study period.
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FIGURE 4 | (A) Distribution of CHD-grades in the Bernese mountain dog
population in Switzerland from 1995 to 2016. (B) Proportion of dysplastic and
CHD-free Bernese mountain dogs in Switzerland from 1995 to 2016: the
prevalence of CHD mildly decreased over 22 years.
Labrador Retriever
Official data of 1512 Labrador Retrievers were available for the
period from 1995 to 2016. Of these, 51 (3.4%) had a BVA/ KC-
score and six (0.4%) dogs an OFA-score that was translated into
the Swiss system. The overall prevalence of CHD was 9.1%,
including 8.5, 0.5, and 0.1% of dogs with grade C, D, and E,
respectively. An A-score was allotted to 54.6% and grade B to
36.3%. In the initial period, 16.5% were scored dysplastic. The
number dropped to 2.9% in the latest period 2010–2016. There
was a remarkable decrease of C-rated dogs (15.7–2.9%) and an
increase of A-rated dogs (36.8–70.6%). More than 90% of the
dogs were CHD-free since 2006.
Flat-Coated Retriever
Overall, 768 Flat-Coated Retriever with an official CHD-score
were registered by the Swiss Retriever Club between 1995 and
2016, of which three (0.4%) were BVA-rated and then translated
into the Swiss system. The overall CHD-prevalence of 5.0%
included 4.6% with grades C, 0.4% with grade D and 0% with
grade E, respectively. The proportion of CHD-free dogs was
95.0%; of these, 65.7% were rated grade A and 29.3% grade B,
respectively. The proportion of dysplastic dogs was initially 6.0%
FIGURE 5 | (A) Distribution of CHD-grades in the German shepherd dog
population in Switzerland from 1995 to 2016. (B) Proportion of dysplastic and
CHD-free German shepherd dogs in Switzerland from 1995 to 2016: the
prevalence of CHD was initially the highest and showed the largest decline
over 22 years compared to the other investigated breeds.
and dropped to 2.6% in the period 2010–2016. Simultaneously,
the proportion of C-rated dogs dropped from 6.0 to 2.6% and the
percentage of A-rated dogs increased from 50.0 to 86.6% in these
years. Responsible for this noticeable increase of A-rated dogs
was not only a reduction of C-dogs but also a decrease of B-rated
dogs: from 44.0% in 1995–1999 to 10.8% in the final period.
Bernese Mountain Dog
The Swiss Club for Bernese Mountain Dogs registered 3,381 dogs
with an official CHD-score between 1995 and 2016. Nine (0.3%)
dogs were BVA/KC-rated.
Dysplastic hip joints were noted in 15.7% of the dogs,
including 11.6, 3.5, and 0.6% of dogs with grade C, D, and E,
respectively. Of the CHD-free dogs (84.3%), 51.6% were rated
as CHD-A and 32.7% as CHD-B. In the initial period (1995–
1999) the CHD-prevalence was 21.2%. It dropped to 12.5% in
2010–2016.While C-rated hip joints decreased from 15.2 to 9.5%,
A-rated dogs increased from 45.8 to 56.7% in these years.
German Shepherd Dog
Data of 5326 German shepherd dogs was available for the study
period. All dogs were scored by the Swiss system. The overall
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prevalence of CHD was 32.4%; of these, 22.5% were scored grade
C and 9.9% grade D or E, respectively. Grade D and E were
summarized in the database of the breeding club and therefore
cannot be shown separately. The proportion of CHD-free dogs
was 67.6%, including 27.9 and 39.7% of dogs with grade A and
B, respectively. When compared to the other breeds, German
shepherd dogs showed the highest prevalence of CHD initially
followed by the steepest decline over 22 years. While 46.2%
of them were dysplastic between 1995 and 1999, the number
dropped to 18.0% in the period 2010–2016. In particular, the
number of A-rated dogs increased from 13.0 to 46.5%, and the
number of C-rated dogs decreased from 31.1 to 14.8%.
Scoring Rate
The rate of radiographed dogs was calculated based on the
number of puppies born per year. Offspring statistics of the
examined breeds were not available for the entire study period.
In the Golden Retriever, 7,947 puppies were registered between
1997 and 2015. Of these 881 dogs were screened for CHD,
representing a scoring rate of 11.1%. In the Labrador retriever,
litter information was available for the period between 2003 and
2016. Of 6,155 dogs born, 866 (14.1%) were officially scored
for CHD. The scoring rate for the 3819 Flat-Coated Retrievers
registered between 1998 and 2015 was 17.3% (659 dogs). In
the Bernese mountain dog, 12,565 puppies were born between
1997 and 2015 of which 2,863 (22.8%) underwent official CHD
screening. The highest scoring rate was noted in the German
shepherd dogs: 13,998 dogs were born between 1997 and 2015
and 4,327 dogs were officially scored, equalling a scoring rate of
30.9%. Scoring rate per year is shown for each breed in Figure 6.
DISCUSSION
Control of CHD in Switzerland started around 1965. Obviously
dysplastic dogs i.e., score D or E have been banned from breeding
in Switzerland since more than 50 years. Nevertheless, the CHD-
rate remained very high for a long time reaching levels above 50%
in some breeds. Between 1991 and 1994, the CHD-prevalence was
FIGURE 6 | Scoring rate in five common large breeds in Switzerland from
1995 to 2016. It was lowest in the Golden Retriever and highest in the German
shepherd dog. However, overall scoring rate was low.
51% in Golden Retrievers, 42% in Labrador Retrievers, 31% in
Flat-Coated Retrievers, 46% in Bernese mountain dogs and 53%
in German shepherd dogs, respectively (15). Since then, between
1995 and 2016, the CHD-prevalence has dropped considerably
in all five breeds. In particular, there was a remarkable decrease
of C-graded dogs and, inversely, an increase of A-graded dogs
in all breeds. Whereas, grades D and E occurred mainly in the
Bernese mountain dog and the German shepherd dog during the
first decade of the investigated period of the present study, these
scores were very rare in the Retriever breeds. During the second
decade, it is interesting to note that in the German shepherd
dog a continuous mild improvement of the hip joint quality was
observed whereas the CHD-prevalence was already on a constant
low level in the other investigated breeds. In other countries a
similar but less pronounced decrease of CHD-prevalence has
been reported. In France a significant decrease of CHD in six
of 15 breeds was noted, e.g., the overall prevalence dropped
from 27% in 1993–1999 to 19% in 2000–2006 in the Bernese
mountain dog (13). In comparison, the overall CHD-prevalence
in the Swiss population of Bernese mountain dogs dropped from
21% in 1995–1999 to 12.5% in 2010–2016. CHD-prevalence in
Switzerland started on a lower level and the reduction was more
pronounced, but observation time was also longer compared to
the French study.
In the United States, a study between 1993 and 2003 showed
only mild to no improvement. The rate of dysplastic Bernese
mountain dogs dropped from about 16–12%, that of Labrador
Retrievers from 12 to 9.5% and that of the Golden Retrievers
from 18 to 15.5%, while the rate for German shepherd dogs
oscillated between 11 and 19% with no clear improvement.
Scoring rate was 5–7% for Retrievers and German shepherd dogs
while it was roughly 24–34% for Bernese mountain dogs (25).
In Finland no improvement was noted in Golden Retrievers,
Labrador Retrievers and German shepherd dogs between 1983
and 1998 (19). In South African Labrador Retrievers only a
minor improvement was seen between 2007 and 2015 (26). It
was beyond the scope of the present study to investigate variables
leading to a decrease in CHD-prevalence in the investigated
breeds; however, several hypotheses may be discussed. Cross-
national general factors may be responsible such as increasing
awareness for inherited diseases by the kennel clubs, breeders and
dog buyers on the one hand and improved training i.e., higher
qualification of the scrutineers on the other hand. Vice versa,
the lack of breeding restrictions associated with a lower scoring
rate may be, in part, responsible for a lower progress in other
countries when compared to the results of the present study. In
Switzerland, for example, pairing C-graded dogs has been banned
10 years ago in German shepherd dogs, and in the Bernese
mountain dog club, C-dogs may only be paired with A-dogs
(https://www.retriever.ch/de/zucht/ankoerung; accessed July 21,
2019; https://www.bernersennenhund.ch/chronik; accessed July
21, 2019). Additionally, the Swiss registry may have helped to
improve genetic hip quality because breeding dogs with better
hips have been selected from the registered pool.
Furthermore, the scoring system in Switzerland is different
from other countries. In all breeds, hip joint radiographs
for official scoring are submitted to and evaluated by two
Frontiers in Veterinary Science | www.frontiersin.org 5 October 2019 | Volume 6 | Article 378
Ohlerth et al. Canine Hip Dysplasia in Switzerland
independent committees only. Additionally, the use of the point
scoring system by Flückiger introduced in the early nineties (4)
may have led to a more objective and stricter evaluation process.
Differences in the prevalence and the course were also noted
between breeds in the present study. Varying heritability, rate
of imported breeding dogs with different genome, and overall
breeding regimen e.g., selection for other genetic diseases may
have played a role.
Currently a purely phenotypic selection mode against hip
dysplasia is used in most breeding clubs worldwide. As long as
no breeding restrictions are enforced it is very unlikely that the
dysplasia rate of offspring can be lowered much further based
on this modality alone. Further improvement may be expected
by several approaches. The key methods are hip joint laxity
measurement, calculation of estimated breeding values, rigid
offspring control and genomic selection.
Hip joint laxity is considered the key factor for the
development of CHD. The standard hip extended ventrodorsal
projection masks hip joint laxity and the degree of laxity may
be quantified by radiographic techniques such as the PennHIP
method, the Fluckiger method or the dorsolateral subluxation
test (27, 28, 28–30). Heritability estimates of the hip-extended
score as well as hip joint laxity measurements have been shown to
be high (31). However, according to a recent study, the Norberg
angle was not an accurate predictor of canine hip conformation
based on the distraction index and the dorsolateral subluxation
score. Authors suggested that application of screening methods
for CHD based on hip laxity (intermediate phenotype screening)
would help to remove additional dysplastic dogs from the
breeding pool (32).
However, the method is also confronted with multiple
obstacles. PennHIP requires a special training and tool and
submission of the radiographs to the company holding the
copyright. Strict adherence to the proposed selection suggestions
(27) would also result in gene loss as more than half of the tested
dogs fail the test in some breeds. Breeders must control additional
undesirable diseases as well such as elbow dysplasia, eye diseases,
epilepsy, cancer, skin disorders and others. Breeders are also
concerned about possible damage to the hip joints and therefore
refuse implementation of a distraction technique. However, there
is no data indicating that application of a distraction method
affects the natural evolution of hip dysplasia and one method,
the dorsolateral subluxation test (28), has been shown not to
place additional stress on the canine hip above walking and
running load.
Breed value estimation (BVE) has been proven to be highly
successful in livestock such as cattle, swine, and poultry. Several
studies estimated that the introduction of BVE in dogs imposes
a more severe downward pressure on hip dysplasia prevalence
than eye balling a pedigree (18, 20, 33–36). The estimated
breeding value is calculated from the phenotype of an individual
and its relatives and their pedigree relationship (21). Including
information about the hip status of relatives has been proven to
be an efficient selection mode in mass selection, as the mode of
inheritance of CHD is still unclear and dogs with phenotypic
normal hip joints may carry undesirable genes passing CHD
to their offspring (21). The effect of BVE however is weak or
even counterproductive when affected dogs are sorted out prior
to official scoring, which is not uncommon practice in German
shepherd dogs worldwide. To profit from BVE, a rigid unbiased
offspring control should be installed. Breeding animals with poor
quality offspring should be banned irrespective of their own
hip status (37). Currently, offspring control rates are low, as
radiography is quite expensive and deep sedation or general
anesthesia is mandatory for the official radiological procedure.
Owners are generally reluctant to have their dogs anesthetised
as long as they are not intended for breeding and show no
clinical signs.
Offspring control is an efficient way to reduce CHD. The
Swiss School for Guide dogs for the Blind achieved impressive
results after including offspring testing in their mass selection.
The CHD-prevalence of their Labrador Retrievers dropped from
58% in the years 1972–1980 to 15% in the period 1991–1996 (38).
The current dysplasia rate is <3%, and of these no D or E grades
are noted (unpublished data, Dysplasia Committee Zurich 2016
and 2017). The school is scoring virtually 100% of the dogs and
adheres to a strict selection scheme. Only dogs with CHD-grades
A and B are used for breeding and information of the relatives are
used when selecting potential breeding animals. Phenotypically
normal sires are eliminated from the breeding stock if their
offspring turns out to be dysplastic. Providing free access of
offspring data to the public is a supplementary way to improve
hip quality. The Swiss Bernese Mountain dog club has been
publishing the offspring grades of each breeding sire since 1990,
as soon as at least 10 offspring have been controlled (https://www.
bernersennenhund.ch/chronik; accessed Sept 9, 2019). Offering
this information allows breeders to exclude sires producing an
excessive number of affected offspring from the breeding stock.
Collection and publication of all data available, including those
of lame elder dogs, should also be encouraged.
As CHD is a hereditary disease, several attempts have been
made to localize the responsible genes (39). A genomic analysis
should increase the accuracy of BVE and thus reduce the rate
of CHD (40, 41). Compared to phenotypic selection, genomic
selection has the advantage that the blood test is relatively
cheap and can be done immediately after birth (42). This
would allow breeders to keep valuable dogs in stock for later
breeding. Currently genomic selection is not possible since the
chromosome location of the genes determining hip conformation
remains largely unknown (43). Hip conformation seems to be
based on many genes with small effects, so that marker-assisted
selection may not be successful either (44). A commercially
available test for German shepherd dogs failed to show any
positive effects and was considered unsuitable for CHD risk
assessment (43). More research in different breeds is needed to
establish genetic tests for early diagnosis and mass screening of
puppies (42).
The overall scoring rate oscillated somewhat over the years.
In Golden and Labrador retriever the rate was low (<15%) and
dropped further. In Bernese Mountain dogs it was almost twice
as high and increased slightly over the past few years. The Swiss
Bernese Mountain Dog club established a health fund in 1999
to encourage its members to actively control the health status
of their dogs (http://www.bernersennenhund.ch/club). This may
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have helped to increase the scoring rate. The highest scoring rate
was noted in the German shepherd dog. This may be associated
with the common use of German Shepherds as working or
sport dogs. However, whereas in German speaking countries
i.e., Austria, Germany and Switzerland, all Retriever, Bernese
Mountain and German shepherd dogs considered for breeding
must be screened for CHD, in most other countries hip control is
not mandatory and therefore only a small fraction of all breeding
dogs is radiographed (26). In the UK for example selection of
dogs used for breeding is left to the discretion of the owners
with no restriction whatsoever (https://www.bva.co.uk/canine-
health-schemes/hip-scheme/, accessed Sept 9, 2019). In the US
no mandatory hip scoring is installed and the OFA registry is
based on voluntary reporting (45, 46).
Some limitations of our results should be addressed. The
scrutinizers in the two dysplasia committees varied over the
entire study period although more than three quarters of all
dogs were scored by the same four experts. Personal experience
and new knowledge acquired over the years may also have
influenced the scoring mode (47). The key limitation in most
studies including the present one is the selection bias of the
raw data (37, 45, 46, 48). Radiographs of dogs with clinical or
obvious radiographic signs of CHD are less commonly submitted
for official evaluation (45). This leads to an underrating of
the true CHD-prevalence in the population. The true CHD-
prevalence can therefore not be determined by scoring potential
breeding stock only. As a consequence the Swiss Bernese
Mountain Club changed their regulation in 2011 and decided
that from every litter a particular number of random chosen dogs
has to be evaluated for CHD (https://www.bernersennenhund.
ch/reglemente-statuten, accessed Sept 9, 2019). Lack of data
on dogs that were treated or euthanized because of CHD
during the first year of life also is a strong bias. Lastly,
radiographic evidence of hip osteoarthritis takes time to develop,
and screening at 1 year of age based on the hip-extended
view inevitably misses later onset and subtle radiographic signs
of CHD.
In conclusion, the present study confirms that the prevalence
of CHD could be reduced efficiently in five common large breeds
in Switzerland over the last two decades using a systematic and
strict phenotypic scoring scheme. However, the true prevalence
of CHD is probably higher than reported. To put more
downward pressure on the incidence and prevalence of CHD,
additional programs should be considered such as breeding only
dogs that are screened by a veterinarian and are publicly available,
intermediate phenotype screening (measurement of joint laxity)
and EBVs.
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